凌嘉鴻

凌嘉鴻 is a Researcher at the Institute of Biochemistry, Academia Sinica, specializing in CRISPR-Cas9 gene editing, immunotherapy, and DNA repair mechanisms. His work focuses on enhancing natural killer (NK) cell therapies, developing adenovirus vectors for DNA delivery, and unraveling CRISPR-Cas9-mediated DNA double-strand break repair processes.

• Ph.D., Microbiology, University of Illinois at Urbana-Champaign
• Postdoc, University of California, Berkeley

His recent research explores CRISPR-Cas9 applications in genomic stability, immune cell engineering, and viral therapy. Key publications include studies on NK cell cytotoxicity enhancement and DNA-free CRISPR gene editing. He has also contributed to structural analyses of Cas9 endonucleases and off-target profiling of CRISPR systems.